Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis

Name: Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis
SKU: 21710
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Category: VOL 48 No. 4 Articles – 2018 Tags: clinical outcomes, first-episode-psychosis, long-acting injectable antipsychotics, observational study, psychotic-disorders, schizophrenia spectrum

Description

Description

Original Research

Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis

By Sofia Medrano, Amal Abdel-Baki, Emmanuel Stip, Stéphane Potvin

25-61_PB-48-4-2018-Medrano

Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis

Description

Original Research

Psychopharmacology Bulletin VOL 47 No. 3, 2017 – Full Issue Stacked PDF

A Perspective on Adolescent Chronic Pain Dismissal

Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder

Title

Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis

Description

Original Research

Related products

Psychopharmacology Bulletin VOL 47 No. 3, 2017 – Full Issue Stacked PDF

A Perspective on Adolescent Chronic Pain Dismissal

Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder

Title